It was found that AD patients and cognitively normal people who tested positive for Aꞵ42 into the cerebrospinal fluid (CSF) had higher tau PET signal in the cortex and neurodegeneration in the hippocampus (Wang et al., 2016). Here, MAPT is linked to Alzheimer disease.